|
|
|
|
| LEADER |
01494nam a2200337Ia 4500 |
| 001 |
10.51821-84.4.009 |
| 008 |
220223s2021 CNT 000 0 und d |
| 245 |
1 |
0 |
|a Clinical assessment and cytokines level in constipation-predominant irritable bowel syndrome participants treated with Lactobacillus-containing cultured milk drink
|
| 260 |
|
0 |
|c 2021
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.51821/84.4.009
|
| 520 |
3 |
|
|a Background: Gut dysbiosis is linked with the pathophysiology of irritable bowel syndrome (IBS). Manipulation of intestinal microbiota using cultured milk drinks may stimulate the immune system, hence providing beneficial support in IBS treatment. This study aimed to investigate the effects of cultured milk drink on clinical symptoms, intestinal transit time (ITT), fecal pH and cytokines in constipation-predominant IBS (IBS-C) as compared to non-IBS participants.
|
| 650 |
0 |
4 |
|a BIFIDOBACTERIUM
|
| 650 |
0 |
4 |
|a cultured milk products
|
| 650 |
0 |
4 |
|a FECAL MICROBIOTA
|
| 650 |
0 |
4 |
|a FERMENTED MILK
|
| 650 |
0 |
4 |
|a IL-6
|
| 650 |
0 |
4 |
|a IL-6
|
| 650 |
0 |
4 |
|a IL-8
|
| 650 |
0 |
4 |
|a Irritable bowel syndrome
|
| 650 |
0 |
4 |
|a PREVALENCE
|
| 650 |
0 |
4 |
|a PROBIOTICS
|
| 650 |
0 |
4 |
|a SYMPTOMS
|
| 650 |
0 |
4 |
|a TNF-alpha
|
| 650 |
0 |
4 |
|a TRANSIT
|
| 700 |
1 |
0 |
|a Alfian, E
|e author
|
| 700 |
1 |
0 |
|a Ali, RAR
|e author
|
| 700 |
1 |
0 |
|a Jaafar, NM
|e author
|
| 700 |
1 |
0 |
|a Mokhtar, NM
|e author
|
| 700 |
1 |
0 |
|a Rani, RA
|e author
|
| 700 |
1 |
0 |
|a Rathi, NDM
|e author
|
| 773 |
|
|
|t ACTA GASTRO-ENTEROLOGICA BELGICA
|
